Metropolis targets 27-28% EBITDA margin via selective M&A
Metropolis Healthcare is sharpening its acquisition strategy and expanding into smaller towns, preventive healthcare adjacencies and specialty diagnostics, targeting 27-28% EBITDA margin over the next three years.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.